本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Redhill Biopharma Ltd

1.98
+0.06623.46%
盘后2.010.0300+1.52%17:00 EDT
成交量:4.00万
成交额:7.79万
市值:346.90万
市盈率:-0.30
高:2.03
开:1.89
低:1.85
收:1.91
数据加载中...
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/04

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals